Effect of Lamotrigine on Quality of Life in Patients with Newly Diagnosed Epilepsy
YU Pei-Min,DING Ding,ZHU Guo-Xing,YU Huan,WEI Guo-Hua,DING Mei-Ping,DI Qing,WU Li-Wen,WANG Yu-Ping,SUN Hong-Bin,WANG Xue-Feng,LIAO Wei-Ping,ZHOU Lie-Min,XIAO Bo,ZHU Sui-Qiang,HUANG Xi-Shun,CHI Zhao-Fu,HONG Zhen
DOI: https://doi.org/10.3969/j.issn.1008-0678.2010.02.011
2010-01-01
Abstract:Aim:To assess the effect of lamotrigine on quality of life after six-month treatment in patients with newly diagnosed epilepsy.Methods:Totally 282 patients with newly diagnosed epilepsy from fourteen study sites in China were enrolled in the study.All the patients started to take lamotrigine as antiepileptic therapy from baseline.The initial dosage and titration procedure were based on regularly clinical practice. Quality of life and cognitive function assessments were taken at the baseline and after 6-month treatment. Quality of life assessment instruments included Short Form 36(SF-36)health survey,QOLIE-31,Hamilton Depression Rating Scale(HAMD),Digital symbol test and questionnaire for woman patients.Results:282 patients completed the final visit,162 male and 120 female.109(46.2%)were seizure free after six-month treatment.All domains of SF-36 scale and seven domains of QOLIE-31 were significantly improved after treatment,except for"general quality of life"in QOLIE-31.The average score of HAM-D was 3.65 at the end point,which was significantly higher than the baseline score 6.42(P<0.01).The score of digital symbol test also indicated a significant progress(P<0.01).Conclusion:Lamotrigine had a favorable effect of efficacy, cognitive function and quality of life in patients with newly diagnosed epilepsy.
What problem does this paper attempt to address?